COVIDITY30 Oct 2022 08:10
As we know, last weeks Results RNS stated:
“Recruitment completed in COVIDITY Phase 1 clinical trial in South Africa, with safety and immunogenicity data expected in Q1 2023, providing read across to our second-generation ImmunoBody® platform”
Noted that clinicaltrials.gov still displays the trial status as “Recruiting” and also the SA Lung Institute recruitment page is still up.
Perhaps a good illustration of the lag in external updates being made and a question mark around the reliability of that information. Unless of course recruitment is left open, even though candidate numbers have been met. I don’t know if the latter is common practice but maybe someone in the know can comment on that point.
Good luck next week all.